Quantcast
Last updated on April 16, 2014 at 7:25 EDT

Latest Stent Stories

2013-09-17 04:22:21

FORT LAUDERDALE, Fla. and NATICK, Mass., Sept. 17, 2013 /PRNewswire/ -- OrbusNeich Medical Inc. and Boston Scientific Corporation (NYSE: BSX) have settled all stent-related litigation between the companies. The agreement resolves cases brought by the parties in Germany, the Netherlands, Ireland, the United Kingdom and the United States. The agreement, which includes a one-time payment from Boston Scientific to OrbusNeich, settles all stent-related disputes between the companies and...

2013-09-12 16:27:47

NATICK, Mass., Sept. 12, 2013 /PRNewswire/ -- In a significant milestone toward obtaining additional key regulatory approvals for the SYNERGY(TM)( )Stent System, Boston Scientific Corporation (NYSE: BSX) has completed enrollment in the EVOLVE II randomized, controlled clinical trial. The EVOLVE II trial is designed to further assess the safety and effectiveness of the SYNERGY Stent System and support U.S. Food and Drug Administration and Japanese regulatory approvals for the...

2013-09-11 23:04:03

Transparency Market Research published new "Global Drug Eluting (DES), Bare Metal (BMS) and Other Coronary Stents Market (2011 – 2016)" market research report to its report store. Browse the report with TOC, visit http://www.transparencymarketresearch.com/coronary-stents-market.html. Albany, New York, USA (PRWEB) September 11, 2013 According to Transparency Market Research “Global Drug Eluting (DES), Bare Metal (BMS) and Other Coronary Stents Market (2011 – 2016)” Global...

2013-09-09 08:28:40

BOSTON, Massachusetts, September 9, 2013 /PRNewswire/ -- InspireMD, Inc. [http://www.inspiremd.com ] (NYSE MKT: NSPR) ("InspireMD" or the "Company"), a leader in embolic protection stents, announced today that it will release its financial results for the fiscal year ended June 30, 2013 on Tuesday, September 17, 2013. The Company will host a conference call on that day at 4:30 p.m. ET to review the Company's financial results and business outlook. Participants should...

2013-09-06 12:25:31

Coating artery-opening stents with a new compound may someday eliminate a common side effect of the treatment, according to preliminary research in the American Heart Association journal Arteriosclerosis, Thrombosis, and Vascular Biology. Stents are tiny mesh tubes that prop open clogged arteries so blood will flow freely to heart muscle, relieving chest pain and reducing the risk of heart attack. But implanting a stent damages the inner lining of the artery, triggering overgrowth of...

2013-09-04 08:32:44

BOSTON, September 4, 2013 /PRNewswire/ -- InspireMD Inc. [http://www.inspire-md.com/site_en ] (NYSE MKT: NSPR) ("InspireMD" or the "Company"), a leader in embolic protection stents, today announced the appointment of Dr. Campbell Rogers to the Board of Directors on September 3, 2013. Dr. Rogers currently serves as the Chief Medical Officer of HeartFlow, Inc. [http://heartflow.com ], a private cardiovascular diagnostics company based in California. "Dr. Rogers has...

2013-09-02 23:00:52

Worldwide study of more than 11,000 female patients provides evidence that stents can be safe and efficient in women who are traditionally underrepresented in clinical trials. New York, NY (PRWEB) September 02, 2013 Cardiac stents to open blocked heart arteries and reduce chest pain have been used for decades. However, cardiologists have never been certain that women benefitted from their use because clinical trials testing stents only included, at most, 25 percent women, making the...

2013-08-30 08:24:58

DUBLIN, August 30, 2013 /PRNewswire/ -- Research and Markets ( http://www.researchandmarkets.com/research/vzrhq6/peripheral) has announced the addition of the "Peripheral Vascular Devices Market (Peripheral Vascular Stents, PTA Balloon Catheters, Guidewires, IVC Filters, Atherectomy, Chronic Total Occlusion, Embolic Protection Devices, Synthetic Surgical Grafts, Aortic Stents) - Global Industry Analysis, Si" [http://www.researchandmarkets.com/research/vzrhq6/peripheral ]...

2013-08-27 23:33:14

Outcomes demonstrate excellent safety and effectiveness in the treatment of patients with Abdominal Aortic Aneurysms (AAA). Santa Rosa, CA (PRWEB) August 27, 2013 The Journal of Vascular Surgery (JVS), the worldwide leader in providing original, peer-reviewed articles on Endovascular Aortic Repair (EVAR), published the one-year outcomes from the TriVascular Ovation global pivotal study. The article concluded the “one-year outcomes with the Ovation stent graft are promising with...

2013-08-26 08:28:50

First stage of manufacturing strategy complete with consolidation of Israeli operations BOSTON, Aug. 26, 2013 /PRNewswire/ -- InspireMD, Inc. (NYSE MKT: NSPR) ("InspireMD" or the "Company"), a leader in embolic protection stents, today announced it has completed the first phase of a manufacturing consolidation that the Company believes will improve its long term gross margins. Simultaneously, the Company has signed an agreement with HealthLink Europe, a medical device support...


Latest Stent Reference Libraries

Interventional Radiology
2013-03-04 16:18:42

Interventional radiology (IR) is a special sub-operation under general radiology. It is used to find, diagnose and treat a disease in almost every body system. The process of interventional radiology is very noninvasive to help with the recovery and outcome of the procedure. It utilizes x-rays, CT, ultrasound, MRI, and other modes of imaging in order to direct tools in the body as well as a variety of catheters, narrow tubes, so that incisions can be minimalized. How it is Performed...

More Articles (1 articles) »